A trauma- and stressor-related disorder that follows exposure to a traumatic event. The 2017 NASEM consensus report found limited evidence that nabilone is effective for improving sleep outcomes in PTSD; broader symptom relief evidence remains limited.
What it is
PTSD is a psychiatric disorder that can develop after exposure to a traumatic event. Core symptoms include intrusive memories, avoidance, negative changes in mood and cognition, and changes in arousal and reactivity.
Cannabis and cannabis-derived therapies
Many state medical cannabis programs include PTSD as a qualifying condition. The clinical evidence base is more limited than for chronic pain or chemotherapy-induced nausea. The 2017 NASEM consensus report classified the evidence as limited, citing one randomized trial of the synthetic cannabinoid nabilone for sleep symptoms. Ongoing trials continue to evaluate whole-plant cannabis and individual cannabinoids for PTSD.
State eligibility for Post-Traumatic Stress Disorder
| State | Qualifies? | Program |
|---|---|---|
| Florida | Yes | Florida OMMU |
| Georgia | Yes | GMCC Low-THC Registry |
| Texas | Yes | Texas Compassionate Use Program |
If your state lists Post-Traumatic Stress Disorder as a qualifying condition, a Miracle Leaf® physician can evaluate you for certification.
Frequently asked questions
Is cannabis effective for PTSD?
The 2017 NASEM report concluded there is limited evidence that nabilone (a synthetic cannabinoid) is effective for improving PTSD symptoms. Specifically sleep outcomes. Broader symptom relief from plant cannabis remains an active area of research without conclusive evidence to date.
Does the VA recommend cannabis for PTSD?
No. The VA/DoD Clinical Practice Guideline for PTSD does not recommend cannabis as a PTSD treatment. The 2023 update explicitly states the evidence is insufficient to recommend for or against cannabis as PTSD therapy. The VA permits veterans to disclose cannabis use without affecting other care.
Why do so many state programs list PTSD as a qualifying condition?
PTSD has been added to state qualifying-condition lists primarily through veteran advocacy and patient-reported benefit, rather than because of rigorous clinical trial evidence. Approximately 30 US states now list PTSD as a qualifying condition.
Are there risks of cannabis for PTSD specifically?
Yes. Cannabis use disorder rates are elevated among trauma-exposed populations. THC can exacerbate anxiety and re-experiencing symptoms in some patients, particularly at higher doses. Cannabis can also impair the effectiveness of trauma-focused psychotherapy if it serves as experiential avoidance.
Patient guidance from Miracle Leaf®
Cannabis is one of several treatment options patients with post-traumatic stress disorder may consider. Our physicians evaluate each patient against the qualifying-condition criteria of their state program and discuss expected benefits and risks based on current clinical evidence. We coordinate with your other treating clinicians where appropriate.
Miracle Leaf® brand products including CBD, Delta-8, and low-THC formulations are available for in-store pickup and nationwide shipping through Miracle Leaf® Store.
Sources and citations
- NASEM: The Health Effects of Cannabis and Cannabinoids (2017)
“Limited evidence that nabilone is effective for improving symptoms of post-traumatic stress disorder.” - VA / DoD Clinical Practice Guideline for PTSD
Last reviewed: 2026-05-17. This page summarizes current peer-reviewed evidence and federal guidance, and is updated whenever the source documents materially change. Not medical advice — consult a licensed clinician before starting or modifying any treatment.